Junginger Th, Kneist W, Schreckenberger M, Menzel C, Oberholzer K, Bartenstein P
Klinik und Poliklinik für Allgemein- und Abdominalchirurgie, Klinikum der Johannes Gutenburg-Universität, Mainz.
Dtsch Med Wochenschr. 2002 Sep 20;127(38):1935-41. doi: 10.1055/s-2002-34198.
Exact preoperative staging is a prerequisite for the indication as well as the choice of the appropriate operative technique for patients with esophageal carcinoma. In this prospective study we assessed whether positron emission tomography (PET) with (18)F-fluorodeoxyglucose (FDG) increases the accuracy of staging compared to standard computer tomography (CT) and leads to a different therapeutic approach.
30 patients (25 men, 5 women, median age 63 years) with histologically identified carcinoma of the esophagus (n =29) and the cardia (n = 1), respectively, were studied. All patients underwent FDG-PET imaging of the neck, chest, and abdomen as well as CT of the chest and abdomen. Sensitivity, specificity and accuracy were calculated for FDG-PET and CT to evaluate the detection of histologically identified lymph node metastases and distant metastatic disease.
FDG-PET showed higher specificity whereas the accuracy of the CT proved to be higher not only for the detection of abdominal lymph node metastases (67 % vs. 46 %), but also for lymph node metastases of the thorax (71 % vs. 50 %). Furthermore, the accuracy of the CT for the detection of blood-bone and lymphatic distant metastases was also higher than that of FDG-PET (72 % vs. 68 %). FDG-PET was more specific (100 % vs. 71 %) albeit less sensitive than CT-imaging (27 % vs. 73 %).
In our study, FDG-PET did not increase the accuracy of standard staging (CT) in patients with carcinoma of the esophagus. Therefore, no new consequences resulted for the operative indication as well as therapeutic procedure. Due to the high costs involved with PET investigation, this form of staging is momentarily indicated mainly for use in clinical studies, and in cases where CT does not offer unequivocal results. Increase in sensitivity of the already advantageous whole-body FDG-PET imaging by means of tumor-affinitive radiopharmaceuticals as well as optimized apparatus resolution could lead to new indications for this staging procedure.
准确的术前分期是食管癌患者选择合适手术技术的前提条件。在这项前瞻性研究中,我们评估了采用(18)F - 氟脱氧葡萄糖(FDG)的正电子发射断层扫描(PET)与标准计算机断层扫描(CT)相比,是否能提高分期的准确性,并导致不同的治疗方法。
研究了30例患者(25例男性,5例女性,中位年龄63岁),分别经组织学确诊为食管癌(n = 29)和贲门癌(n = 1)。所有患者均接受了颈部、胸部和腹部的FDG - PET成像以及胸部和腹部的CT检查。计算FDG - PET和CT的敏感性、特异性和准确性,以评估对组织学确诊的淋巴结转移和远处转移疾病的检测情况。
FDG - PET显示出更高的特异性,而CT的准确性不仅在检测腹部淋巴结转移方面更高(67%对46%),在检测胸部淋巴结转移方面也更高(71%对50%)。此外,CT检测血行骨转移和淋巴远处转移的准确性也高于FDG - PET(72%对68%)。FDG - PET更具特异性(100%对71%),尽管其敏感性低于CT成像(27%对73%)。
在我们的研究中,FDG - PET并未提高食管癌患者标准分期(CT)的准确性。因此,在手术指征和治疗程序方面没有产生新的影响。由于PET检查费用高昂,这种分期形式目前主要适用于临床研究以及CT结果不明确的情况。通过肿瘤亲和性放射性药物以及优化设备分辨率来提高已具优势的全身FDG - PET成像的敏感性,可能会为这种分期程序带来新的应用指征。